| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
105609
Status
Published
Date of creation
2014-06-12 14:48 UTC (ana.diaz@ica.gov.co)
Date of last update
2014-06-12 19:49 UTC (jbocanegra@humboldt.org.co)
Date of publication
2014-06-12 19:49 UTC (jbocanegra@humboldt.org.co)

This document is also available in the following languages:
General Information
Country
  • Colombia
Title of risk assessment
ES
Uso del producto INNOVAX ND SB, vacuna aviar para la enfermedad de Marek y la enfermedad de Newcastle serotipos 2 y 3 virus vivo, vector vivo de la enfermedad de Marek.
Date of the risk assessment
Date not available
Competent National Authority(ies) responsible for the risk assessment
Instituto Colombiano Agropecuario ICA
Calle 26 #85B - 09 Piso 8
BOGOTA, CUNDINAMARCA
Colombia
Phone:+57 1 3323700 ext 1361 o 1367
Email:subgerencia.agricola@ica.gov.co,alberto.rosero@ica.gov.co
Url:http://www.ica.gov.co
Contact details of the main responsible risk assessor
Sr MARTIN EMILIO RODRIGUEZ MOSQUERA
PROFESIONAL ESPECIALIZADO
INSTITUTO COLOMBIANO AGROPECUARIO ICA (ICA)
CRA 41 #17-81 ZONA INDUSTRIAL PUENTE ARANDA.
BOGOTA, CUNDINAMARCA
Colombia
Phone:0571-3323700 EXT 1366 1361
Fax:0571-3323700
Email:martin.rodriguez@ica.gov.co
Risk assessment details
Living modified organism
INNOVAX® ND Vaccine
Dr Leonardo Bruno Ribeiro Costa Production of medical or pharmaceutical compounds (human or animal) - Vaccines
Scope of the risk assessment
  • OVM para uso farmacéutico
Risk assessment report / Summary

Records referencing this document (1)
IDDescription
1record(s) found
Country's Decision or any other Communication1 record